Home > Income Statement > WINDLAS BIOTECH

WINDLAS BIOTECH
Consolidated Net Profit

    Back to Income Statement
WINDLAS BIOTECH is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹66 Cr₹61 Cr₹58 Cr₹43 Cr₹38 Cr

What is the latest Consolidated Net Profit of WINDLAS BIOTECH ?

The latest Consolidated Net Profit ratio of WINDLAS BIOTECH is ₹66 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹66 Cr
Mar2025₹61 Cr
Mar2024₹58 Cr
Mar2023₹43 Cr
Mar2022₹38 Cr

How is Consolidated Net Profit of WINDLAS BIOTECH Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹66 Cr
8.95
Mar2025 ₹61 Cr
4.82
Mar2024 ₹58 Cr
36.51
Mar2023 ₹43 Cr
11.91
Mar2022 ₹38 Cr -

Compare Consolidated Net Profit of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹2,046.1 Cr 6.3% 15.6% -5.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,090.0 Cr 1% -2.7% 15.7% Stock Analytics
DIVIS LABORATORIES ₹226,976.0 Cr 0.7% 17.1% 40.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,639.0 Cr -0.3% -3.7% 37.9% Stock Analytics
CIPLA ₹115,216.0 Cr -0.3% 2.3% -8.1% Stock Analytics
DR REDDYS LABORATORIES ₹98,074.4 Cr -1.4% 0.7% -6.2% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

6.3%

15.6%

-5.8%

SENSEX

-0.6%

1%

-3.7%


You may also like the below Video Courses